March 7, 2017 / 9:13 PM / 5 months ago

BRIEF-Aerie Pharmaceuticals reports Q4 GAAP loss per share of $0.87

1 Min Read

March 7 (Reuters) - Aerie Pharmaceuticals Inc

* Aerie Pharmaceuticals reports fourth quarter and full year 2016 financial results and provides business update

* Q4 adjusted loss per share $0.72

* Q4 earnings per share view $-0.67 -- Thomson Reuters I/B/E/S

* Q4 GAAP loss per share $0.87

* Rhopressa NDA resubmitted, and readouts from rocket 4 and mercury 2 on track for Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below